BiOasis Technologies Valuation
| BIOAF Stock | USD 0.0004 0.0003 300.00% |
BiOasis Technologies seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of biOasis Technologies from examining the firm fundamentals such as Current Valuation of 6 M, shares outstanding of 79.41 M, and Return On Asset of -0.81 as well as analyzing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that BiOasis Technologies' price fluctuation is out of control at this time. Calculation of the real value of biOasis Technologies is based on 3 months time horizon. Increasing BiOasis Technologies' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the BiOasis pink sheet is determined by what a typical buyer is willing to pay for full or partial control of biOasis Technologies. Since BiOasis Technologies is currently traded on the exchange, buyers and sellers on that exchange determine the market value of BiOasis Pink Sheet. However, BiOasis Technologies' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4.0E-4 | Real 3.1E-4 | Hype 3.39E-4 | Naive 4.47E-4 |
The real value of BiOasis Pink Sheet, also known as its intrinsic value, is the underlying worth of biOasis Technologies Company, which is reflected in its stock price. It is based on BiOasis Technologies' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of BiOasis Technologies' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of biOasis Technologies helps investors to forecast how BiOasis pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of BiOasis Technologies more accurately as focusing exclusively on BiOasis Technologies' fundamentals will not take into account other important factors: BiOasis Technologies Total Value Analysis
biOasis Technologies is currently forecasted to have takeover price of 6 M with market capitalization of 2.13 M, debt of 401.76 K, and cash on hands of 764.97 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the BiOasis Technologies fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
6 M | 2.13 M | 401.76 K | 764.97 K |
BiOasis Technologies Investor Information
The company recorded a loss per share of 0.03. biOasis Technologies had not issued any dividends in recent years. Based on the key indicators related to BiOasis Technologies' liquidity, profitability, solvency, and operating efficiency, biOasis Technologies is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.BiOasis Technologies Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. BiOasis Technologies has an asset utilization ratio of 1.66 percent. This implies that the Company is making $0.0166 for each dollar of assets. An increasing asset utilization means that biOasis Technologies is more efficient with each dollar of assets it utilizes for everyday operations.BiOasis Technologies Ownership Allocation
BiOasis Technologies holds a total of 79.41 Million outstanding shares. Nearly 97.95 percent of BiOasis Technologies outstanding shares are held by general public with 2.05 (percent) owned by insiders and only 0.0 % by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.BiOasis Technologies Profitability Analysis
The company reported the revenue of 37.73 K. Net Loss for the year was (2.96 M) with loss before overhead, payroll, taxes, and interest of (1.15 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates BiOasis Technologies' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in BiOasis Technologies and how it compares across the competition.
About BiOasis Technologies Valuation
The pink sheet valuation mechanism determines BiOasis Technologies' current worth on a weekly basis. Our valuation model uses a comparative analysis of BiOasis Technologies. We calculate exposure to BiOasis Technologies's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of BiOasis Technologies's related companies.Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut. Bioasis Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct BiOasis Technologies' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates BiOasis Technologies' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct BiOasis Technologies' valuation analysis, follow these 8 steps:- Gather financial information: Obtain BiOasis Technologies' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine BiOasis Technologies' revenue streams: Identify BiOasis Technologies' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research BiOasis Technologies' industry and market trends, including the size of the market, growth rate, and competition.
- Establish BiOasis Technologies' growth potential: Evaluate BiOasis Technologies' management, business model, and growth potential.
- Determine BiOasis Technologies' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate BiOasis Technologies' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
BiOasis Technologies Growth Indicators
Investing in growth stocks can be very risky. If the company such as BiOasis Technologies does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 72.9 M | |
| Retained Earnings | -40.7 M |
Complementary Tools for BiOasis Pink Sheet analysis
When running BiOasis Technologies' price analysis, check to measure BiOasis Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiOasis Technologies is operating at the current time. Most of BiOasis Technologies' value examination focuses on studying past and present price action to predict the probability of BiOasis Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiOasis Technologies' price. Additionally, you may evaluate how the addition of BiOasis Technologies to your portfolios can decrease your overall portfolio volatility.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |